| Parkview Medical Group, Inc. | |
|
9041 Magnolia Ave Suite 107 Riverside CA 92503-3900 | |
| (951) 353-1021 | |
| (951) 687-0692 |
| Full Name | Parkview Medical Group, Inc. |
|---|---|
| Speciality | Clinic/Center |
| Location | 9041 Magnolia Ave, Riverside, California |
| Authorized Official Name and Position | Jennifer Chapman (ADMINISTRATOR) |
| Authorized Official Contact | 9513531021 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Parkview Medical Group, Inc. 9041 Magnolia Ave Suite 107 Riverside CA 92503-3900 Ph: (951) 353-1021 | Parkview Medical Group, Inc. 9041 Magnolia Ave Suite 107 Riverside CA 92503-3900 Ph: (951) 353-1021 |
| NPI Number | 1114339207 |
|---|---|
| Provider Enumeration Date | 05/23/2014 |
| Last Update Date | 06/23/2020 |
| Medicare PECOS PAC ID | 0345565925 |
|---|---|
| Medicare Enrollment ID | O20150203001408 |
News Archive
The Chase Foundation, a nonprofit dedicated to financially supporting hospital-based programs that cater to the social, emotional and developmental needs of children, has donated $2.125 million to the Child Life/Child Development program at Mattel Children's Hospital UCLA.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
One fourth of the adult and children population of California have no access to insurance. 6.4 million people were uninsured in 2007 and figures jumped up to 8.2 million in just 2 years. Recession and unemployment was thought to be the major contributing factor according to the investigators from UCLA's Center for Health Policy Research.
Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has granted Jose M. Garcia, MD, PhD, Assistant Professor, Division of Diabetes Endocrinology and Metabolism, Departments of Medicine and Molecular and Cell Biology, Baylor College of Medicine and Michael I. DeBakey Veterans Administration Medical Center, in Houston Texas, an Investigational New Drug approval for the initiation of a Phase 2A trial to assess the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130, in patients with cancer cachexia.
Array BioPharma Inc. (Nasdaq: ARRY) announced its preliminary analysis of results from a study examining ARRY-162, a small molecule MEK inhibitor, in a 12-week Phase 2 clinical trial with 201 patients.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114339207 | NPI | - | NPPES |
| Provider Name | Larry H Couture |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1649295676 PECOS PAC ID: 9335106525 Enrollment ID: I20041220000646 |
News Archive
The Chase Foundation, a nonprofit dedicated to financially supporting hospital-based programs that cater to the social, emotional and developmental needs of children, has donated $2.125 million to the Child Life/Child Development program at Mattel Children's Hospital UCLA.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
One fourth of the adult and children population of California have no access to insurance. 6.4 million people were uninsured in 2007 and figures jumped up to 8.2 million in just 2 years. Recession and unemployment was thought to be the major contributing factor according to the investigators from UCLA's Center for Health Policy Research.
Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has granted Jose M. Garcia, MD, PhD, Assistant Professor, Division of Diabetes Endocrinology and Metabolism, Departments of Medicine and Molecular and Cell Biology, Baylor College of Medicine and Michael I. DeBakey Veterans Administration Medical Center, in Houston Texas, an Investigational New Drug approval for the initiation of a Phase 2A trial to assess the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130, in patients with cancer cachexia.
Array BioPharma Inc. (Nasdaq: ARRY) announced its preliminary analysis of results from a study examining ARRY-162, a small molecule MEK inhibitor, in a 12-week Phase 2 clinical trial with 201 patients.
› Verified 4 days ago
| Provider Name | Carol Anne Barnes-blanks |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1720009152 PECOS PAC ID: 2163420068 Enrollment ID: I20061130000331 |
News Archive
The Chase Foundation, a nonprofit dedicated to financially supporting hospital-based programs that cater to the social, emotional and developmental needs of children, has donated $2.125 million to the Child Life/Child Development program at Mattel Children's Hospital UCLA.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
One fourth of the adult and children population of California have no access to insurance. 6.4 million people were uninsured in 2007 and figures jumped up to 8.2 million in just 2 years. Recession and unemployment was thought to be the major contributing factor according to the investigators from UCLA's Center for Health Policy Research.
Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has granted Jose M. Garcia, MD, PhD, Assistant Professor, Division of Diabetes Endocrinology and Metabolism, Departments of Medicine and Molecular and Cell Biology, Baylor College of Medicine and Michael I. DeBakey Veterans Administration Medical Center, in Houston Texas, an Investigational New Drug approval for the initiation of a Phase 2A trial to assess the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130, in patients with cancer cachexia.
Array BioPharma Inc. (Nasdaq: ARRY) announced its preliminary analysis of results from a study examining ARRY-162, a small molecule MEK inhibitor, in a 12-week Phase 2 clinical trial with 201 patients.
› Verified 4 days ago
| Provider Name | Shawn Couture |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1548464175 PECOS PAC ID: 3072675602 Enrollment ID: I20081216000473 |
News Archive
The Chase Foundation, a nonprofit dedicated to financially supporting hospital-based programs that cater to the social, emotional and developmental needs of children, has donated $2.125 million to the Child Life/Child Development program at Mattel Children's Hospital UCLA.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
One fourth of the adult and children population of California have no access to insurance. 6.4 million people were uninsured in 2007 and figures jumped up to 8.2 million in just 2 years. Recession and unemployment was thought to be the major contributing factor according to the investigators from UCLA's Center for Health Policy Research.
Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has granted Jose M. Garcia, MD, PhD, Assistant Professor, Division of Diabetes Endocrinology and Metabolism, Departments of Medicine and Molecular and Cell Biology, Baylor College of Medicine and Michael I. DeBakey Veterans Administration Medical Center, in Houston Texas, an Investigational New Drug approval for the initiation of a Phase 2A trial to assess the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130, in patients with cancer cachexia.
Array BioPharma Inc. (Nasdaq: ARRY) announced its preliminary analysis of results from a study examining ARRY-162, a small molecule MEK inhibitor, in a 12-week Phase 2 clinical trial with 201 patients.
› Verified 4 days ago
| Provider Name | Jesse L Guadiz |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1558317933 PECOS PAC ID: 5991855306 Enrollment ID: I20090605000239 |
News Archive
The Chase Foundation, a nonprofit dedicated to financially supporting hospital-based programs that cater to the social, emotional and developmental needs of children, has donated $2.125 million to the Child Life/Child Development program at Mattel Children's Hospital UCLA.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
One fourth of the adult and children population of California have no access to insurance. 6.4 million people were uninsured in 2007 and figures jumped up to 8.2 million in just 2 years. Recession and unemployment was thought to be the major contributing factor according to the investigators from UCLA's Center for Health Policy Research.
Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has granted Jose M. Garcia, MD, PhD, Assistant Professor, Division of Diabetes Endocrinology and Metabolism, Departments of Medicine and Molecular and Cell Biology, Baylor College of Medicine and Michael I. DeBakey Veterans Administration Medical Center, in Houston Texas, an Investigational New Drug approval for the initiation of a Phase 2A trial to assess the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130, in patients with cancer cachexia.
Array BioPharma Inc. (Nasdaq: ARRY) announced its preliminary analysis of results from a study examining ARRY-162, a small molecule MEK inhibitor, in a 12-week Phase 2 clinical trial with 201 patients.
› Verified 4 days ago
| Provider Name | Jason M Couture |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1962609115 PECOS PAC ID: 8325214018 Enrollment ID: I20111230000149 |
News Archive
The Chase Foundation, a nonprofit dedicated to financially supporting hospital-based programs that cater to the social, emotional and developmental needs of children, has donated $2.125 million to the Child Life/Child Development program at Mattel Children's Hospital UCLA.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
One fourth of the adult and children population of California have no access to insurance. 6.4 million people were uninsured in 2007 and figures jumped up to 8.2 million in just 2 years. Recession and unemployment was thought to be the major contributing factor according to the investigators from UCLA's Center for Health Policy Research.
Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has granted Jose M. Garcia, MD, PhD, Assistant Professor, Division of Diabetes Endocrinology and Metabolism, Departments of Medicine and Molecular and Cell Biology, Baylor College of Medicine and Michael I. DeBakey Veterans Administration Medical Center, in Houston Texas, an Investigational New Drug approval for the initiation of a Phase 2A trial to assess the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130, in patients with cancer cachexia.
Array BioPharma Inc. (Nasdaq: ARRY) announced its preliminary analysis of results from a study examining ARRY-162, a small molecule MEK inhibitor, in a 12-week Phase 2 clinical trial with 201 patients.
› Verified 4 days ago
| Provider Name | Jean Everly Lafontant |
|---|---|
| Provider Type | Practitioner - Preventive Medicine |
| Provider Identifiers | NPI Number: 1043501851 PECOS PAC ID: 7315262870 Enrollment ID: I20150205000003 |
News Archive
The Chase Foundation, a nonprofit dedicated to financially supporting hospital-based programs that cater to the social, emotional and developmental needs of children, has donated $2.125 million to the Child Life/Child Development program at Mattel Children's Hospital UCLA.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
One fourth of the adult and children population of California have no access to insurance. 6.4 million people were uninsured in 2007 and figures jumped up to 8.2 million in just 2 years. Recession and unemployment was thought to be the major contributing factor according to the investigators from UCLA's Center for Health Policy Research.
Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has granted Jose M. Garcia, MD, PhD, Assistant Professor, Division of Diabetes Endocrinology and Metabolism, Departments of Medicine and Molecular and Cell Biology, Baylor College of Medicine and Michael I. DeBakey Veterans Administration Medical Center, in Houston Texas, an Investigational New Drug approval for the initiation of a Phase 2A trial to assess the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130, in patients with cancer cachexia.
Array BioPharma Inc. (Nasdaq: ARRY) announced its preliminary analysis of results from a study examining ARRY-162, a small molecule MEK inhibitor, in a 12-week Phase 2 clinical trial with 201 patients.
› Verified 4 days ago
News Archive
The Chase Foundation, a nonprofit dedicated to financially supporting hospital-based programs that cater to the social, emotional and developmental needs of children, has donated $2.125 million to the Child Life/Child Development program at Mattel Children's Hospital UCLA.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
One fourth of the adult and children population of California have no access to insurance. 6.4 million people were uninsured in 2007 and figures jumped up to 8.2 million in just 2 years. Recession and unemployment was thought to be the major contributing factor according to the investigators from UCLA's Center for Health Policy Research.
Aeterna Zentaris Inc. today announced that the U.S. Food and Drug Administration has granted Jose M. Garcia, MD, PhD, Assistant Professor, Division of Diabetes Endocrinology and Metabolism, Departments of Medicine and Molecular and Cell Biology, Baylor College of Medicine and Michael I. DeBakey Veterans Administration Medical Center, in Houston Texas, an Investigational New Drug approval for the initiation of a Phase 2A trial to assess the safety and efficacy of repeated doses of the Company's ghrelin agonist, AEZS-130, in patients with cancer cachexia.
Array BioPharma Inc. (Nasdaq: ARRY) announced its preliminary analysis of results from a study examining ARRY-162, a small molecule MEK inhibitor, in a 12-week Phase 2 clinical trial with 201 patients.
› Verified 4 days ago
Innovative Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4500 Brockton Ave Ste 305, Riverside, CA 92501 Phone: 206-445-9978 Fax: 858-280-3279 | |
Pulmonary Partners Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5790 Magnolia Ave, Suite 201, Riverside, CA 92506 Phone: 951-368-0427 Fax: 951-368-0429 | |
Lyn M Pintelon D.o. Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8990 Garfield St, Ste.6, Riverside, CA 92503 Phone: 951-358-0784 Fax: 951-354-7583 | |
Precision Spinal Care Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4224 Cedar Pine Ct, Riverside, CA 92505 Phone: 909-648-0377 | |
Parkview Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3722 Tibbetts St, Riverside, CA 92506 Phone: 951-784-3770 | |
Orangecrest Medical Group, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4646 Brockton Ave Ste 203, Riverside, CA 92506 Phone: 951-774-2881 Fax: 951-774-2846 | |
Harmony Health Solutions Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5750 Division St Ste 208, Riverside, CA 92506 Phone: 310-560-9292 |